Personalised surveillance after treatment for high-risk cancer

Oncotarget. 2019 Jan 22;10(7):694-695. doi: 10.18632/oncotarget.26619.

Authors

Christina Guo¹, Jeremy Lewin¹, Mark Shackleton¹

Affiliation

¹ Mark Shackleton: Cancer Treatment and Development Laboratory, Central Clinical School, Monash University, Victoria, Australia; Department of Oncology, Alfred Health, Victoria, Australia.

No abstract available

Keywords: PET; cancer; ctDNA; melanoma; surveillance.

Publication types

Editorial